Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06469801 · ClinicalTrials.gov registry record · NA
ECMO ABI Detection With Hyperfine
A NA study of Stroke, Acute and Extracorporeal Membrane Oxygenation Complication, sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06469801 is a NA study of Stroke, Acute and Extracorporeal Membrane Oxygenation Complication that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 30 participants, below the 629-participant average among 25 other Stroke, Acute trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06469801, a NA study of Stroke, Acute and Extracorporeal Membrane Oxygenation Complication, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.
Conditions Studied
Interventions
- DEVICE Hyperfine
Study Locations (1)
Missouri
- Children's Mercy - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06469801
The ClinicalTrials.gov registry entry for NCT06469801 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 629-participant average among 25 other Stroke, Acute trials with a reported enrollment target (95% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stroke, Acute appearing as the primary indexed condition, and to 1 intervention - of which Hyperfine is the first listed.
NCT06469801 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06469801 about?
NCT06469801 is a clinical study titled "ECMO ABI Detection With Hyperfine". The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinic...
What is the current status of trial NCT06469801?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-07-23. Estimated completion is 2026-07-01.
What conditions does trial NCT06469801 study?
This clinical trial studies the following conditions: Stroke, Acute, Extracorporeal Membrane Oxygenation Complication, Hypoxia-Ischemia, Brain, Acute Brain Injury.
What interventions are being tested in trial NCT06469801?
The interventions under investigation include: Hyperfine (DEVICE).
Who is sponsoring clinical trial NCT06469801?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06469801 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
-
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
RECRUITING · NA
-
EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography
RECRUITING · NA
Explore more on PlainTrial
Stroke, Acute
All registered trials for this condition
Extracorporeal Membrane Oxygenation Complication
All registered trials for this condition
Missouri
All trials with a study site in Missouri
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.